PM20D1 activates a key molecule to help the brain clear Alzheimer's better

Researchers have identified a molecular mechanism that strengthens the aging brain's capacity to eliminate toxic Alzheimer's deposits. The protein PM20D1 generates a compound called N-oleoyl-leucine (OLE), which instructs microglia—the brain's immune cells—to attack and clear amyloid-β aggregates more efficiently. In animal models of Alzheimer's, OLE induced microglia to associate directly with amyloid plaques, reducing their size, number, and toxicity while improving neuroprotection and cognitive performance. The compound also enhanced immune cells' ability to detect and clear amyloid-β in cell cultures and protected neurons subjected to Alzheimer's-related stress. Crucially, researchers also found evidence that this PM20D1-OLE mechanism functions in human Alzheimer's brains, opening the door to therapies that modulate microglia rather than pursuing amyloid-β clearance alone—an approach that has yielded limited results thus far.